You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Intersect ENT is a company surfaced as a portfolio company of kleiner-perkins and added to the API Evangelist network as a stub for enrichment. Sector: healthcare. This profile is a lead awaiting the enrichment pipeline.
Backed by: kleiner-perkins
About
Intersect ENT was a medical device company based in Menlo Park, California that developed drug-eluting, bioresorbable sinus implants for patients with chronic rhinosinusitis. Its PROPEL family of steroid-eluting implants maintains sinus patency and delivers localized mometasone furoate to the sinus mucosa following endoscopic sinus surgery, while…